Apyx Medical Corporation (APYX) vs Caribou Biosciences, Inc. (CRBU)

A side-by-side comparison of Apyx Medical Corporation and Caribou Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — APYX vs CRBU

growth of $100 · dividends reinvested · last 5y
APYX -72.2% (-22.6%/yr)CRBU -92.7% (-40.8%/yr)APYX compounded faster over this window
050100150Start $10020222023202420252026$28$7
APYX CRBU

APYX vs CRBU: by the numbers

  • •CRBU is the larger company ($116M vs $110M market cap).
  • •Both run net losses; APYX's is the smaller (-14.78% vs -1030.42% net margin).
  • •APYX grew revenue faster over the past five years (8.82% vs -2.03% CAGR).

Metrics side by side

Valuation

MetricAPYXCRBU
P/S ratio1.8911.59
P/B ratio10.331.19

Profitability

MetricAPYXCRBU
Gross margin33.94%67.34%
Operating margin-6.06%-1220.49%
Net margin-14.78%-1030.42%
ROE-80.97%-105.40%
ROIC-6.84%-87.72%

Growth (annualized)

MetricAPYXCRBU
Revenue CAGR (5Y)8.82%-2.03%
Total return CAGR (5Y)-28.10%-44.43%

Frequently asked

Which has grown faster, APYX or CRBU?
Over the past five years, APYX grew revenue faster — APYX at a 8.82% CAGR versus CRBU at -2.03%.
How have APYX and CRBU total returns compared?
Over the past 5 years, APYX delivered -28.10% and CRBU delivered -44.43% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.